ZYXI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

25.53M

-44.47%

-0.110

+450%

25.95M

-2.36%

-0.110

-66.67%

24.74M

+10.99%

-0.110

-83.33%

Estimates Revision

The market is revising Upward the revenue expectations for Zynex, Inc. (ZYXI) for FY2025, with the revenue forecasts being adjusted by 4.38% over the past three months. During the same period, the stock price has changed by -91.32%.

Revenue Estimates for FY2025

Revise Upward

+4.38%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-4.3%

In Past 3 Month

Stock Price

Go Down

-91.32%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast ZYXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZYXI is USD with a low forecast of 3.70 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

1 Hold

0 Sell

Hold

Current: 0.000

Low

3.70

Averages

High

3.70

Current: 0.000

Low

3.70

Averages

High

3.70

H.C. Wainwright

Yi Chen

Buy -> Neutral

downgrade

2025-08-01

Reason

H.C. Wainwright

Yi Chen

Price Target

2025-08-01

downgrade

Buy -> Neutral

Reason

H.C. Wainwright analyst Yi Chen downgraded Zynex to Neutral from Buy without a price target. The company reported a Q2 miss and an operational restructuring is in progress, the analyst tells investors in a research note. The firm says there is no visibility at this point as to when Tricare payments to Zynex will resume.

Ladenburg

Neutral -> Buy

upgrade

$3.70

2025-08-01

Reason

Ladenburg

Price Target

$3.70

2025-08-01

upgrade

Neutral -> Buy

Reason

Ladenburg upgraded Zynex to Buy from Neutral with a $3.70 price target.

Ladenburg

Neutral -> Buy

upgrade

$3.70

2025-08-01

Reason

Ladenburg

Price Target

$3.70

2025-08-01

upgrade

Neutral -> Buy

Reason

As previously reported, Ladenburg upgraded Zynex to Buy from Neutral with a $3.70 price target. While the firm recognizes disruptions in the pain segment are "material," creating uncertainty and negatively impacting the company's performance, it argues that the opportunity for the NiCO laser pulse oximeter "should not be overlooked," citing the differentiated technology and agency-driven efforts to provide more equitable care.

RBC Capital

Sector Perform

downgrade

$4 -> $3

2025-07-15

Reason

RBC Capital

Price Target

$4 -> $3

2025-07-15

downgrade

Sector Perform

Reason

RBC Capital lowered the firm's price target on Zynex to $3 from $4 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 results for MedTech names. Based on the firm's intra-quarter diligence with key opinion leaders and company management / investor discussions, there is a high level of interest in MedTech and multiple opportunities across the sector, the analyst tells investors in a research note. Regarding the company however, the firm notes that sentiment on the stock is quite negative given its Q1 miss and no guidance issued for 2025.

HC Wainwright & Co.

Yi Chen

Strong Buy

Maintains

$17 → $15

2025-03-12

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$17 → $15

2025-03-12

Maintains

Strong Buy

Reason

Ladenburg Thalmann

Jeffrey Cohen

Strong Buy

Hold

Downgrades

n/a

2025-03-12

Reason

Ladenburg Thalmann

Jeffrey Cohen

Price Target

n/a

2025-03-12

Downgrades

Strong Buy

Hold

Reason

Ladenburg downgraded Zynex to Neutral from Buy without a price target saying the company continues to adjust operationally amid revenue pressure.

Valuation Metrics

The current forward P/E ratio for Zynex Inc (ZYXI.O) is 15.04, compared to its 5-year average forward P/E of 21.15. For a more detailed relative valuation and DCF analysis to assess Zynex Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

21.15

Current PE

15.04

Overvalued PE

36.02

Undervalued PE

6.29

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.24

Current EV/EBITDA

8.55

Overvalued EV/EBITDA

20.46

Undervalued EV/EBITDA

0.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

1.85

Current PS

0.98

Overvalued PS

2.87

Undervalued PS

0.82

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ZYXI News & Events

Events Timeline

No data

News

2.0

2025-12-17Benzinga

Aditxt Shares Surge Approximately 63%; Check Out 20 Stocks Making Moves in Premarket Trading

4.5

2025-12-16Benzinga

Dow Declines by 50 Points; US Employment Increases by 64,000 in November

9.5

2025-12-16Benzinga

B. Riley Financial Shares Surge Approximately 25%; Check Out 20 Stocks Making Moves in Premarket Trading

People Also Watch

Frequently Asked Questions

What is Zynex Inc (ZYXI) stock price today?

The current price of ZYXI is 0 USD — it has decreased -53.6 % in the last trading day.

What is Zynex Inc (ZYXI)'s business?

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

What is the price predicton of ZYXI Stock?

Wall Street analysts forecast ZYXI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZYXI is USD with a low forecast of 3.70 USD and a high forecast of 3.70 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Zynex Inc (ZYXI)'s revenue for the last quarter?

Zynex Inc revenue for the last quarter amounts to 13.36M USD, decreased -73.26 % YoY.

What is Zynex Inc (ZYXI)'s earnings per share (EPS) for the last quarter?

Zynex Inc. EPS for the last quarter amounts to -1.42 USD, decreased -2128.57 % YoY.

What changes have occurred in the market's expectations for Zynex Inc (ZYXI)'s fundamentals?

How many employees does Zynex Inc (ZYXI). have?

Zynex Inc (ZYXI) has 1000 emplpoyees as of January 10 2026.

What is Zynex Inc (ZYXI) market cap?

Today ZYXI has the market capitalization of 286.93M USD.